Drug intelligence / Profile preview

Galminor

Development stage
Unknown
Lead developer
Genetic
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

**Galminor** is a prescription ophthalmic fixed-dose combination marketed by Offhealth. It contains the aminoglycoside antibacterial **netilmicin** at 3 mg/mL and the corticosteroid anti-inflammatory **dexamethasone** at 1 mg/mL as dexamethasone sodium phosphate. It is supplied as an eye-drop solution in multidose and single-dose presentations for inflammatory conditions of the anterior eye segment, including postoperative inflammation, when bacterial infection is present or considered a risk. Netilmicin inhibits bacterial protein synthesis through binding to the bacterial 30S ribosomal subunit, while dexamethasone activates glucocorticoid receptors to suppress ocular inflammation.

Brand names
Galminor
02

Targets

GR (Glucocorticoid receptor)Bacterial Ribosome

Beyond the preview

Go deeper on Galminor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Galminor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call